Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Eli Lilly and Company naming Micheál Martin .
Filed returns
6
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | Eli Lilly and Company | Health | IPHA Framework Agreement for the Supply of Innovative Medicines. (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Eli Lilly and Company | EU Affairs | Advocate for improved EU Environment to support investment in medicines innovation and manufacturing (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Eli Lilly and Company | Economic Development and Industry | Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Eli Lilly and Company | Economic Development and Industry | Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2021 | Eli Lilly and Company | Economic Development and Industry | EU Pharmaceutical Strategy (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2016 | Eli Lilly and Company | Economic Development and Industry | Dr Lechleiter briefed Mr Martin on Lilly's most recent investments in Ireland. The economic recovery was discussed as well as the current business environment generally for FDI in Ireland as it relates to companies such… (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 4 | 66.7% | |
| EU Affairs | 1 | 16.7% | |
| Health | 1 | 16.7% |